During the last session, Imunon Inc (NASDAQ:IMNN)’s traded shares were 0.33 million, with the beta value of the company hitting 2.02. The 52-week high for the IMNN share is $3.65, that puts it down -280.21 from that peak though still a striking 50.0% gain since the share price plummeted to a 52-week low of $0.48. The company’s market capitalization is $13.88M, and the average intraday trading volume over the past 10 days was 0.12 million shares, and the average trade volume was 271.80K shares over the past three months.
Imunon Inc (IMNN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IMNN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.36.
Imunon Inc (NASDAQ:IMNN) trade information
Imunon Inc (IMNN) registered a 0.02% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.02% in intraday trading to $0.96, hitting a weekly high. The stock’s 5-day price performance is 6.65%, and it has moved by 15.39% in 30 days. Based on these gigs, the overall price performance for the year is 62.32%. The short interest in Imunon Inc (NASDAQ:IMNN) is 0.97 million shares and it means that shorts have 2.38 day(s) to cover.
Imunon Inc (IMNN) estimates and forecasts
Statistics show that Imunon Inc has outperformed its competitors in share price, compared to the industry in which it operates. Imunon Inc (IMNN) shares have gone down -20.79% during the last six months, with a year-to-date growth rate more than the industry average at 22.22% against 16.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.62%. While earnings are projected to return 22.22% in 2025, the next five years will return 25.45% per annum.
IMNN Dividends
Imunon Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Imunon Inc (NASDAQ:IMNN)’s Major holders
Imunon Inc insiders own 1.09% of total outstanding shares while institutional holders control 7.03%, with the float percentage being 7.11%. COLONY GROUP, LLC is the largest shareholder of the company, while 24.0 institutions own stock in it. As of 2024-06-30, the company held over 35000.0 shares (or 0.3723% of all shares), a total value of $50000.0 in shares.
The next largest institutional holding, with 66.0 shares, is of FEDERATION DES CAISSES DESJARDINS DU QUEBEC’s that is approximately 0.0007% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $77.0.
Also, the Mutual Funds coming in first place with the largest holdings of Imunon Inc (IMNN) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 80.62 shares. This amounts to just over 0.56 percent of the company’s overall shares, with a $77207.0 market value. The same data shows that the other fund manager holds slightly less at 48.81, or about 0.34% of the stock, which is worth about $46741.0.
